7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Caribou Biosciences Inc
(NASDAQ:CRBU) 

CRBU stock logo

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

Founded: 2011
CEO / Co-Founder: Rachel Haurwitz 
Sector:
Industry:
BiotechnologyOncologyGene Editing
Share this website to your friends
Caribou Biosciences Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 025.7851.5677.35103.13128.91154.69180.48
Caribou Biosciences Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3,643.65-3,072.78-2,501.91-1,931.04-1,360.17-789.3-218.44352.43
Caribou Biosciences Days Inventory Outstanding ttm (DIO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 054.32108.65162.97217.29271.61325.94380.26
Caribou Biosciences Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.15-1.84-1.54-1.23-0.92-0.61-0.310
Caribou Biosciences Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.28-1.95-1.63-1.3-0.98-0.65-0.330
Caribou Biosciences Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.81.62.43.244.85.59
Caribou Biosciences P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2,544.01-2,156.15-1,768.28-1,380.41-992.54-604.67-216.8171.07
Caribou Biosciences (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -7.52-6.45-5.37-4.3-3.22-2.15-1.070
Caribou Biosciences P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.260.530.791.051.321.581.84
No extra charts and metrics for this ticker.